Home › Free Stock Grades › OCUL
Ocular Therapeutix, Inc. (OCUL) Stock Grade
OCUL · Healthcare
C
Market Cap
$1.7B
P/E Ratio
—
Revenue Growth (YoY)
-18.7%
Net Margin
-513.2%
Return on Equity
—
Dividend Yield
None
About Ocular Therapeutix, Inc.'s fundamentals
Ocular Therapeutix is a biotechnology company with a market capitalization of $1.7 billion that reported declining revenues, with a year-over-year contraction of 18.7% in its latest period. The company posted a significant net loss, reflected in a net margin of -513.2%, meaning it spent $5.13 for every dollar of revenue generated. As a pre-profitability biotech firm, the company does not pay a dividend and traditional profitability metrics like P/E ratio and return on equity are not applicable.